Table 2.
Clinical characteristics at admission and treatment of patients hospitalized with COVID-19 who did or did not develop critical illness.
| Total (n = 523) | Critical illness |
P-valuea | ||
|---|---|---|---|---|
| No (n = 413) | Yes (n = 110) | |||
| Unconsciousness, n (%) | 88 (16.8) | 53 (12.8) | 35 (31.8) | <0.001 |
| Dyspnoea, n (%) | 238 (45.5) | 163 (39.5) | 75 (68.2) | <0.001 |
| Haemoptysis, n (%) | 5 (1) | 3 (0.7) | 2 (1.8) | 0.296 |
| Chest pain, n (%) | 81 (15.5) | 68 (16.5) | 13 (11.8) | 0.231 |
| Fever, n (%) | 378 (72.3) | 289 (70) | 89 (80.9) | 0.23 |
| Dry cough, n (%) | 338 (64.6) | 267 (63.9) | 74 (67.3) | 0.514 |
| Headache, n (%) | 53 (10.1) | 48 (11.6) | 5 (4.5) | 0.029 |
| Rash, n (%) | 3 (0.6) | 3 (3.7) | 0 | 0.37 |
| Anosmia, n (%) | 31 (5.9) | 28 (6.8) | 3 (2.7) | 0.11 |
| Temperature >38 °C or <36 °C, n (%) | 138 (26.4) | 78 (18.9) | 60 (54.5) | <0.001 |
| Heart rate >90 beats/min, n (%) | 123 (23.5) | 80 (19.4) | 43 (39.1) | <0.001 |
| Respiratory rate, n (%) | <0.001 | |||
| <20 breaths/min | 271 (51.8) | 234 (56.7) | 37 (33.6) | |
| 20–30 breaths/min | 105 (20.1) | 60 (14.5) | 45 (40.9) | |
| >30 breaths/min | 22 (4.2) | 5 (1.2) | 17 (15.5) | |
| Unknown | 123 (23.5) | 112 (27.1) | 11 (10) | |
| Systolic blood pressure <100 mmHg, n (%) | 36 (6.9) | 27 (6.5) | 9 (8.2) | 0.645 |
| SaO2 <90%, n (%) | 105 (20.1) | 63 (15.3) | 42 (38.2) | <0.001 |
| High COVID-GRAM, n (%) | 122 (23.3) | 63 (15.3) | 59 (53.6) | <0.001 |
| CURB-65 score ≥ 2, n (%) | 197 (37.7) | 126 (30.5) | 71 (64.5) | <0.001 |
| qSOFA score ≥ 2, n (%) | 13 (2.48) | 7 (1.7) | 6 (5.5) | 0.002 |
SaO2, oxygen saturation.
a
Chi-square test.